From: Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model
Indel classification | n | Ratio (%) | Indel classification | n | Ratio (%) | Indel classification | n | Ratio (%) |
---|---|---|---|---|---|---|---|---|
Del-coding | 2.93 | 0.14 | Het InDels | 1927.41 | 93.27 | Total deletion | 1225.63 | 59.31 |
Ins-coding | 1.26 | 0.06 | Hom InDels | 139.14 | 6.73 | Total insertion | 840.92 | 40.69 |
Splice-site | 0.80 | 0.04 | Â | Â | Â | Â | Â | Â |
Intron | 2030.18 | 97.28 | Â | Â | Â | Â | Â | Â |
5′UTRs | 3.00 | 0.14 |  |  |  |  |  |  |
3′UTRs | 47.00 | 2.25 |  |  |  |  |  |  |
Promo | 1.68 | 0.08 | Â | Â | Â | Â | Â | Â |
Intergenic | 0.00 | 0.00 | Â | Â | Â | Â | Â | Â |
Total number of indels | 2066.55 |